Verve Therapeutics (VERV)
NASDAQ:VERV
US Market
Holding VERV?
Track your performance easily

Verve Therapeutics (VERV) Cash flow

468 Followers

Verve Therapeutics Cash Flow

VERV's free cash flow for Q1 2024 was $-43.52M. For the 2024 fiscal year, VERV's free cash flow was decreased by $-23.27M and operating cash flow was $-43.08M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -143.53M$ -149.55M$ -122.33M$ -77.10M$ -35.27M$ -7.44M
Investing Cash Flow
$ -29.33M$ 27.69M$ -155.96M$ -239.10M$ -51.13M$ -12.76M
Financing Cash Flow
$ 233.27M$ 212.58M$ 328.96M$ 376.31M$ 92.63M$ 17.95M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 517.94M$ 210.95M$ 120.24M$ 69.57M$ 9.46M$ 3.22M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 31.71M$ 31.71M$ 39.99M$ 285.21M$ 92.62M$ 18.04M
Issuance Of Debt
----$ 0.00$ 24.00K
Repayment Of Debt
----$ 0.00$ -110.00K
Free Cash Flow
$ -107.01M$ -158.83M$ -135.56M$ -81.46M$ -38.69M$ -9.30M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Verve Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis